Back to MACKENZIE FINANCIAL CORP MACKENZIE FINANCIAL CORP

KROSKROS
5 quarters

Position history for MACKENZIE FINANCIAL CORPMACKENZIE FINANCIAL CORP's holdings in KEROS THERAPEUTICS INC

MACKENZIE FINANCIAL CORP holds 628,438 shares of KROS (KEROS THERAPEUTICS INC), worth $6.7M as of 2026-Q2. The position was increased (+312.2% shares). KROS represents 0.0% of MACKENZIE FINANCIAL CORP's portfolio.

Current Value

$6.7M

Current Shares

628,438

Total Value Change

+$6M

Total Shares Change

+574,561

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
628,438
+312.2%
$6.7M0.0%$10.70
44
2026-Q1
Increased
152,450
+196.7%
$1.7M0.0%$13.40
41
2025-Q4
Decreased
51,385
-9.5%
$1M0.0%$20.27
0
2025-Q3
Increased
56,768
+5.4%
$898,0700.0%$15.95
26
2025-Q2
New
53,877
-
$719,2580.0%$13.49
34

Other major holders of KROS: BlackRock Finance, Inc., RA CAPITAL MANAGEMENT, L.P., ALKEON CAPITAL MANAGEMENT LLC, VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used